David W. Denning is an infectious diseases clinician with expertise in fungal diseases.
He serves as the chief executive of the Global Action Fund for Fungal infections (GAFFI) and professor of Infectious Diseases and Global Health at the University of Manchester, UK. Denning was the founding Director of the UK’s National Aspergillosis Centre, Manchester (2009-2020). His current academic interests are chronic and allergic pulmonary fungal disease, the global burden of fungal infection, resistance in aspergillus, and the development of new antifungal agents.
Edouard Drouhet medal, European Confederation of Medical Mycology, 2017
Third P Talwar Oration, Chandigarh, India, 2015
Fellow, Academy of Medical Sciences, 2010
MacFarlane Burnett Lecturer, Australasian Society of Infectious Diseases, 2005
Page, I.D., Byanyima, R., Hosmane, S., Onyachi N.,... Denning, D.W. (2019 ). Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Resp J, 18(53), pii: 1801184. DOI: 10.1183/13993003.01184-2018.
Denning, D.W., Kneale, M., Sobel, J.D., & Rautemaa-Richardson, R. (2018). Global burden of recurrent vulvovaginal candidiasis. Lancet Infect Dis, 18(11), e339-e347. DOI: 10.1016/S1473-3099(18)30103-8.
Denning, D.W., Perlin, D.S., Muldoon, E.G., Colombo, A.L., et al. (2017). Delivering on the antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis,23(2), 177-183. DOI: 10.3201/eid2302.152042
Cole, D.C., Govender, N.P., Chakrabarti, C., Sacarlal, J. (2017). Improving fungal disease identification and management – combined health systems and public health approaches are needed. Lancet Infect Dis, 17(12), e412-e419. DOI: 10.1016/S1473-3099(17)30308-0
Bongomin, F., Gago, S., Oladele, R.O., & Denning, D.W. (2017). Global and national prevalence of fungal diseases-estimate precision. J Fungi (Basel), 3(4), pii:E57. DOI: 10.3390/jof3040057.